FAM126A Gene Leukodystrophy Hypomyelinating Type 5 NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The FAM126A Gene Leukodystrophy Hypomyelinating Type 5 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the FAM126A gene, which is crucial for proper myelin formation in the central nervous system. This specialized genetic test provides essential insights into hypomyelinating leukodystrophy type 5, a rare neurological condition affecting brain development and function.
What This Advanced Genetic Test Detects
Our comprehensive NGS-based analysis specifically targets the FAM126A gene to identify pathogenic variants responsible for leukodystrophy hypomyelinating type 5. The test examines:
- Point mutations and small insertions/deletions in the FAM126A gene
- Genetic variations affecting myelin basic protein expression
- Mutations impacting oligodendrocyte development and function
- Inherited genetic patterns associated with autosomal recessive leukodystrophy
Who Should Consider This Genetic Testing
This specialized genetic test is recommended for individuals presenting with:
- Unexplained developmental delays in infancy or early childhood
- Progressive neurological deterioration with motor impairment
- Family history of leukodystrophy or similar neurological disorders
- Abnormal brain MRI findings showing hypomyelination
- Nystagmus, ataxia, or spasticity of unknown origin
- Suspected hereditary white matter diseases
Significant Benefits of Early Genetic Diagnosis
Undergoing the FAM126A genetic testing provides numerous advantages:
- Accurate diagnosis enabling targeted treatment approaches
- Early intervention strategies for symptom management
- Comprehensive genetic counseling for family planning
- Clear understanding of disease progression and prognosis
- Eligibility for clinical trials and specialized care programs
- Peace of mind through definitive diagnostic clarity
Understanding Your Genetic Test Results
Our genetic specialists provide detailed interpretation of your results:
- Positive Result: Indicates presence of pathogenic FAM126A mutations, confirming diagnosis of hypomyelinating leukodystrophy type 5
- Negative Result: Suggests absence of detectable FAM126A mutations, though other genetic causes may need investigation
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals with single mutation who may pass the condition to offspring
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Accessibility
We proudly offer comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures you receive expert care regardless of your location.
Take the Next Step Toward Genetic Clarity
Don’t let uncertainty about neurological symptoms affect your quality of life. Our FAM126A Gene Leukodystrophy Hypomyelinating Type 5 NGS Genetic DNA Test provides the definitive answers you need for informed healthcare decisions. With our discounted price of $500 and comprehensive genetic counseling support, you can gain valuable insights into your neurological health.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take control of your neurological health with advanced genetic diagnostics from America’s trusted genetics laboratory.
